Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-06-13
ABSIAbsci CorpJonasson ZachariahCFO , CBOS - Sale+OE$4.98-19,859384,751-5%-$98,892
2024-06-12
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$60.00-19,16466,377-22%-$1,149,840
M
2024-06-07
MXCTMaxcyte, Inc.Masoud MaherPres, CEOP - Purchase$4.89+100,000100,000New+$489,066
2024-06-06
INCYIncyte CorpTray ThomasPrincipal Accounting OfficerS - Sale$58.91-1,09321,634-5%-$64,389
2024-06-05
MEDPMedpace Holdings, Inc.Burwig Susan EEVP, OperationsS - Sale$401.20-7,6817,500-51%-$3,081,617
AD
2024-03-08
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale+OE$267.52-8087,825-9%-$216,156
M
2024-05-24
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$395.38-9,6825,387,6750%-$3,828,058
2024-05-24
OABIOmniab, Inc.Foehr Matthew WPres, CEOP - Purchase$4.42+240,0003,536,665+7%+$1,059,840
2024-05-22
ABSIAbsci CorpPhoenix Venture Partners II LP10%S - Sale$4.40-3,100,00011,279,522-22%-$13,640,000
2024-05-22
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.00-555,397,3570%-$22,000
2024-05-20
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.19-4,0205,397,4120%-$1,608,764
M
2024-05-15
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$404.76-39,3425,401,432-1%-$15,924,222
2024-05-15
CRLCharles River Laboratories International, Inc.Massaro GeorgeDirS - Sale$235.62-3325,855-5%-$78,225
2024-05-10
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$226.97-1,30423,276-5%-$295,969
2024-05-10
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$402.89-4,9565,440,7740%-$1,996,723
M
2024-05-08
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.41-8,2685,445,7300%-$3,310,566
M
2024-05-06
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$403.20-52,4045,453,998-1%-$21,129,347
M
2024-05-01
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$401.33-16,3305,506,4020%-$6,553,671
M
2024-04-29
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.65-16,9305,522,7320%-$6,782,987
D
2024-04-08
OABIOmniab, Inc.Gustafson Kurt AEVP, Finance, CFOS - Sale+OE$5.27-6,954176,697-4%-$36,648
D
2024-04-08
OABIOmniab, Inc.Berkman Charles SGCS - Sale+OE$5.27-6,954292,617-2%-$36,648
D
2024-04-01
OABIOmniab, Inc.Gustafson Kurt AEVP, Finance, CFOS - Sale+OE$5.46-11,849170,110-7%-$64,696
D
2024-03-26
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$4.41-5,000120,583-4%-$22,025
2024-03-22
OABIOmniab, Inc.Foehr Matthew WPres, CEOP - Purchase$5.19+225,0002,908,803+8%+$1,167,750
2024-03-15
MEDPMedpace Holdings, Inc.Burwig Susan EEVP, OperationsS - Sale$403.00-10215,181-1%-$41,106
D
2024-03-14
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$409.87-250250-50%-$102,468
2024-03-08
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale$267.52-8087,024-10%-$216,156
M
2024-03-06
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$411.61-200,0005,539,662-3%-$82,321,250
M
2024-03-06
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$411.61-200,0004,733,019-4%-$82,321,250
D
2024-03-07
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$415.00-4720-100%-$195,880
D
2024-03-04
MEDPMedpace Holdings, Inc.Geiger Jesse JPresS - Sale+OE$403.03-22,32121,503-51%-$8,996,033
M
2024-03-04
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$402.91-100,0005,739,662-2%-$40,291,000
M
2024-03-04
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$402.91-100,0004,933,019-2%-$40,291,000
2024-03-01
ABSIAbsci CorpRedmile Group, LLCDirP - Purchase$4.50+222,2228,253,316+3%+$999,999
2024-03-04
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale$261.05-2,7507,832-26%-$717,890
2024-03-01
NRCNational Research CorpCommon Property Trust10%S - Sale$40.54-598,6533,854,284-13%-$24,269,393
D
2024-03-01
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$250.53-31,6781,328,885-2%-$7,936,193
2024-02-29
IQVIqvia Holdings Inc.Staub W RichardSee RemarksS - Sale$247.80-14,10015,945-47%-$3,494,034
M
2024-02-29
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$400.25-100,0005,033,019-2%-$40,024,600
M
2024-02-29
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.25-100,0005,839,662-2%-$40,024,600
2024-02-29
CRLCharles River Laboratories International, Inc.Parisotto Shannon MCEVP, Disc, Safety AssessmentS - Sale$253.45-3,78633,686-10%-$959,545
2024-02-29
CRLCharles River Laboratories International, Inc.Creamer Victoria LEVP, Chief People OfficerS - Sale$253.70-5,00013,550-27%-$1,268,500
D
2024-02-28
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$250.17-8,607652-93%-$2,153,176
M
2024-02-29
MEDPMedpace Holdings, Inc.Ewald Stephen PGC, Corp. Secy.S - Sale$395.19-1,51313,341-10%-$597,923
2024-02-29
MEDPMedpace Holdings, Inc.Geiger Jesse JPresS - Sale$393.51-2,5583,824-40%-$1,006,586
D
2024-02-28
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$405.00-5000-100%-$202,500
M
2024-02-27
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$403.01-100,0005,133,019-2%-$40,300,500
M
2024-02-23
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$401.07-156,9286,039,662-3%-$62,938,689
M
2024-02-23
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$401.07-156,9285,233,019-3%-$62,938,689
2024-02-22
CRLCharles River Laboratories International, Inc.Barbo William DCorporate EVP, CCOS - Sale$248.50-4,05026,914-13%-$1,006,425
M
2024-02-21
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$392.66-136,0125,389,947-2%-$53,406,441
M
2024-02-21
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$392.66-136,0126,196,590-2%-$53,406,441
2024-02-16
IQVIqvia Holdings Inc.Sherbet EricSee RemarksS - Sale$241.50-1,00020,836-5%-$241,500
D
2024-02-16
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$241.10-13,468652-95%-$3,247,165
M
2024-02-16
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$390.58-63,9885,525,959-1%-$24,992,323
M
2024-02-16
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$390.58-63,9886,332,602-1%-$24,992,323
D
2024-02-15
CRLCharles River Laboratories International, Inc.Parisotto Shannon MCEVP, Disc, Safety AssessmentS - Sale+OE$241.21-5,88237,884-13%-$1,418,767
2024-02-15
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$238.93-83824,620-3%-$200,223
2024-02-06
FOXOFoxo Technologies Inc.Ward Martin ChristopherInterim CFO, 10%S - Sale$0.42-250,0001,300,000-16%-$105,000
2024-02-06
FOXOFoxo Technologies Inc.White Mark BrianInterim CEO, 10%S - Sale$0.42-250,0001,300,000-16%-$105,000
D
2024-01-26
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$5.12-5,000120,583-4%-$25,585
2019-06-07
NOTVInotiv, Inc.Leasure Robert Jr.Pres, CEOP - Purchase$1.98+7,500146,434+5%+$14,864
M
2024-01-04
NRCNational Research CorpAmandla Mk Trust10%S - Sale$40.85-7,2144,755,3170%-$294,710
2024-01-03
NRCNational Research CorpCommon Property Trust10%S - Sale$41.53-364,6254,452,937-8%-$15,142,876
2024-01-03
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale$65.51-7,36590,218-8%-$482,481
M
2024-01-02
NRCNational Research CorpAmandla Mk Trust10%S - Sale$40.86-321,2394,762,531-6%-$13,125,005
2024-01-02
INCYIncyte CorpIyengar Vijay KEVP, GMAPPSS - Sale$65.00-65743,412-1%-$42,705
D
2023-12-26
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$4.53-5,000120,583-4%-$22,650
2023-12-21
RNGERange Impact, Inc.Cavanaugh Michael R.CEOP - Purchase$0.15+1,000,0001,879,791+114%+$150,000
2023-12-21
RNGERange Impact, Inc.Feighan Edward FDirP - Purchase$0.15+666,6673,690,917+22%+$100,000
M
2023-12-14
MEDPMedpace Holdings, Inc.Burwig Susan EEVP, OperationsS - Sale$303.96-12,40015,283-45%-$3,769,150
D
2023-12-14
CRLCharles River Laboratories International, Inc.Creamer Victoria LEVP, Chief People OfficerS - Sale+OE$225.00-5,52616,506-25%-$1,243,350
D
2023-12-14
NOTVInotiv, Inc.Garrett MichaelChief Commercial OfficerP - Purchase$2.83+5,00016,467+44%+$14,145
D
2023-12-14
NOTVInotiv, Inc.Beattie John GregoryCOOP - Purchase$3.12+47,966111,761+75%+$149,836
M
2023-12-12
MLCTRange Impact, Inc.Loconti Joseph E.10%P - Purchase$0.16+106,78320,827,180+1%+$17,080
M
2023-12-12
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.55-26,2635,083,770-1%-$1,091,264
M
2023-12-12
INCYIncyte CorpTray ThomasPrincipal Accounting OfficerS - Sale$61.55-1,27723,436-5%-$78,594
2023-12-12
OABIOmniab, Inc.Foehr Matthew WCEOP - Purchase$5.05+200,0002,645,442+8%+$1,010,000
M
2023-12-07
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.55-54,7045,110,033-1%-$2,273,206
M
2023-12-04
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.60-2,5505,164,7370%-$106,080
DM
2023-12-04
MXCTMaxcyte, Inc.Doerfler DouglasPres, CEOS - Sale+OE$5.14-124,450333,197-27%-$639,405
D
2023-12-01
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$214.03-13,1171,973-87%-$2,807,472
DM
2023-11-29
MXCTMaxcyte, Inc.Doerfler DouglasPres, CEOS - Sale+OE$5.00-25,550333,197-7%-$127,750
M
2023-11-29
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$272.86-53,1676,396,590-1%-$14,507,101
M
2023-11-29
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$272.86-53,1675,589,947-1%-$14,507,101
2023-11-30
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$197.73-1,85023,133-7%-$365,801
D
2023-11-27
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$4.59-5,000120,583-4%-$22,950
M
2023-11-27
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$274.96-46,8335,643,114-1%-$12,877,319
M
2023-11-27
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$274.96-46,8336,449,757-1%-$12,877,319
2023-11-22
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$277.81-25,0006,496,5900%-$6,945,250
2023-11-22
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$277.81-25,0005,689,9470%-$6,945,250
M
2023-11-20
NRCNational Research CorpAmandla Mk Trust10%S - Sale$42.07-7845,167,2870%-$32,987
2023-11-21
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$277.37-25,0005,714,9470%-$6,934,250
2023-11-21
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$277.37-25,0006,521,5900%-$6,934,250
2023-11-20
CRLCharles River Laboratories International, Inc.Girshick BirgitCorporate EVP, COOP - Purchase$187.82+1,32244,449+3%+$248,298
M
2023-11-17
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$274.68-100,0006,546,590-2%-$27,468,000
2023-11-15
NRCNational Research CorpAmandla Mk Trust10%S - Sale$42.10-4035,168,0710%-$16,968
D
2023-11-14
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$3.71-10,000120,583-8%-$37,100
M
2023-11-14
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$282.91-75,0006,646,590-1%-$21,217,980
M
2023-11-14
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$282.91-75,0005,839,947-1%-$21,217,980

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top